Form 8-K - Current report:
SEC Accession No. 0001347613-18-000023
Filing Date
2018-06-12
Accepted
2018-06-12 17:23:17
Documents
1
Period of Report
2018-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sgyp-8kproxyvote.htm 8-K 66828
  Complete submission text file 0001347613-18-000023.txt   68125
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 18895285
SIC: 2834 Pharmaceutical Preparations